
US pharmaceutical firm Pfizer has sold off its remaining stake in Sensodyne and Panadol maker Haleon for around £2.5 billion.
Haleon has agreed to buy back 44 million shares from Pfizer for £3.85 a share – totalling about £170 million – as part of the deal, with the remaining 618 million shares being sold to institutional investors.